Riskpilot← Back to searchSign inGet full accessCORTICALIS AS
ASActiveOrg 890353002Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20065 employeeswww.corticalis.no
Revenue 2024
NOK 4M
+32% vs 2023
EBITDA margin
-132.5%
-53% vs 2023
Equity ratio
74.7%
Financial strength
Net profit 2024
NOK -3,7M
-6% vs 2023
| Revenue | NOK 4M | +32% |
| EBITDA | NOK -5,3M | -53% |
| Net profit | NOK -3,7M | -6% |
| Total assets | NOK 19,3M | +3% |
| Equity | NOK 14,4M | -21% |
| Employees | 5 | — |
Legal name
CORTICALIS AS
Org number
890353002
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. oktober 2006
Share capital
NOK 928 232
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Forskning og utviklingsarbeid innen odontologi, medisin, naturvitenskap og teknikk. Produksjon og markedsføring av produkter innen odontologi, medisin, naturvitenskap og teknikk. Investeringer og eierskap i andre selskaper.
Address
Gaustadalléen 21, 0349 Oslo
Email
ellingsen@corticalis.com
Website
www.corticalis.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 6 944 | 7 624 | 8 302 | 8 309 | 2 996 | 4 057 | 3 805 | 3 365 | 2 886 | 1 576 | 1 715 | 2 283 | 1 371 | 1 866 | 3 046 | 4 021 |
| Staff expenses | −0 | −0 | −0 | −1 017 | −1 405 | −1 568 | −455 | −707 | −1 494 | −1 551 | −1 155 | −405 | −1 160 | −621 | −415 | −339 | −1 335 | −2 038 |
| EBITDA | 0 | −114 | 4 922 | 3 760 | 2 578 | 595 | −1 150 | −1 686 | −1 309 | 91 | −1 452 | −1 137 | 8 563 | −2 342 | −1 258 | −3 302 | −3 473 | −5 329 |
| Depreciation & amort. | −0 | −0 | −0 | −2 | −46 | −56 | −98 | −256 | −225 | −201 | −214 | −63 | −49 | −35 | −43 | −41 | −48 | −52 |
| EBIT | 0 | −114 | 4 922 | 3 758 | 2 532 | 539 | −1 247 | −1 942 | −1 534 | −110 | −1 666 | −1 200 | 8 514 | −2 377 | −1 301 | −3 343 | −3 521 | −5 381 |
| Net financials | 0 | −0 | −912 | 72 | 32 | 120 | 92 | 68 | 29 | 10 | −8 | 3 | −9 | −46 | 10 | −85 | 1 | 1 664 |
| Profit before tax | 0 | −115 | 4 011 | 3 830 | 2 564 | 659 | −1 155 | −1 875 | −1 505 | −100 | −1 674 | −1 197 | 8 505 | −2 423 | −1 291 | −3 428 | −3 521 | −3 717 |
| Tax | −0 | −0 | 976 | 864 | 445 | −103 | −572 | −912 | −593 | −145 | 2 325 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −115 | 3 034 | 2 966 | 2 119 | 762 | −583 | −963 | −912 | 44 | −3 999 | −1 197 | 8 505 | −2 423 | −1 291 | −3 428 | −3 521 | −3 717 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 182 | 2 012 | 6 620 | 9 344 | 9 191 | 7 398 | 8 180 | 5 796 | 5 856 | 2 037 | 185 | 10 824 | 9 027 | 8 236 | 7 741 | 18 748 | 19 271 |
| Equity | — | 172 | 1 589 | 4 565 | 6 683 | 7 445 | 6 863 | 5 900 | 4 988 | 5 032 | 1 033 | −164 | 8 341 | 7 623 | 6 332 | 5 911 | 18 111 | 14 394 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 700 | 763 | 1 538 | 0 | 0 | 0 |
| Short-term debt | 0 | 10 | 423 | 2 053 | 2 660 | 1 745 | 535 | 2 280 | 809 | 824 | 1 003 | 349 | 783 | 641 | 366 | 1 829 | 637 | 4 877 |
| Total debt | 0 | 10 | 423 | 2 055 | 2 660 | 1 745 | 535 | 2 280 | 809 | 824 | 1 003 | 349 | 2 483 | 1 404 | 1 904 | 1 829 | 637 | 4 877 |
EBITDA margin
-132.5%
This company
15.8%
Market median
-939% vs market
20072024
Equity ratio
74.7%
This company
38.2%
Market median
+96% vs market
20072024
Return on equity
-25.8%
This company
18.4%
Market median
-240% vs market
20072024
Net profit margin
-92.4%
This company
8.1%
Market median
-1241% vs market
20072024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20072024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HJ Deputy Member | Deputy Member | 2018 | — | — |
SP Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Prosano As | Company | 31.3% | 31.3% | 2023 |
Lyngstadaas Biomedical Consulting As | Company | 19.6% | 19.6% | 2023 |
Svarthøi Holding As | Company | 15.9% | 15.9% | 2023 |
As Clipper | Company | 3.8% | 3.8% | 2023 |
Gabriellen As | Company | 3.8% | 3.8% | 2023 |
R2b Of Sweden Ab | Company | 3.5% | 3.5% | 2023 |
Rønold Consulting As | Company | 3.0% | 3.0% | 2023 |
Ikos Subsidiary As | Company | 2.5% | 2.5% | 2023 |
Nickina International Consulting Ab | Company | 2.2% | 2.2% | 2023 |
Capedel Holding As | Company | 2.1% | 2.1% | 2023 |
Mur, Skifer & Betong As | Company | 1.9% | 1.9% | 2023 |
Bixby Holding As | Company | 1.3% | 1.3% | 2023 |
Villard & Bræ:Nd As | Company | 1.3% | 1.3% | 2023 |
Pamar As | Company | 1.3% | 1.3% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svarthøi Holding As
CORTICALIS AS Board members of CORTICALIS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Jacob Rønold | Deputy Member | 0 companies |
| Ståle Petter Lyngstadaas | Chief Executive Officer | 0 companies |
| Håvard Jostein Haugen | Board of Directors | 0 companies |
| Jan Eirik Ellingsen | Chairman | 0 companies |
| Erlend Basmo Ellingsen | Board of Directors | 0 companies |
| Bjørn Gabriel Reed | Board of Directors | 0 companies |
| René Willi | Board of Directors | 0 companies |
| John Mikael Sander | Board of Directors | 0 companies |